CorTec Achieves Neurotech Milestone with German BCI Implantation

CorTec GmbH has announced the successful first human implantation of its Brain Interchange™ system. This German-developed brain-computer interface (BCI) is now part of a clinical trial at Harborview Medical Center in Seattle. The trial aims to evaluate the BCI's efficacy in enhancing upper-limb motor recovery in stroke patients through direct cortical electrical stimulation.

The trial is led by Jeffrey G. Ojemann, MD, and is funded by the NIH. It seeks to determine whether the BCI can leverage neuroplasticity to improve rehabilitation outcomes. The implant records brain signals and provides real-time electrical stimulation tailored to patient needs.

Dr. Frank Desiere, CEO of CorTec, emphasized the significance of this milestone, marking CorTec as Germany’s pioneer in implantable BCI technology. The innovation offers hope to millions of stroke patients by potentially improving their quality of life and independence.